iCAD, Inc. to Present at Acumen Biofin Rodman & Renshaw 9th Annual Healthcare Conference

NASHUA, N.H., Oct. 29 /PRNewswire-FirstCall/ -- iCAD, Inc. (Nasdaq: ICAD - News), an industry-leading provider of Computer-Aided Detection (CAD) solutions for the early identification of cancer, today announced that Ken Ferry, Chief Executive Officer, and Darlene Deptula-Hicks, Executive Vice President and Chief Financial Officer, will be presenting a corporate update at the Acumen Biofin Rodman & Renshaw 9th Annual Healthcare Conference on Wednesday, November 7th at 8:50 a.m. (Eastern Standard Time) at the New York Palace Hotel in New York.

MORE ON THIS TOPIC